A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Part of paid clinical trials in Chandler, Arizona.
- Sponsor
- Incyte Corporation
- Study ID
- NCT07284849
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- CRC (Colorectal Cancer)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- INCA33890 — DRUGINCA33890 will be administered at protocol defined dose.
- Placebo — DRUGPlacebo will be administered at protocol defined dose.
- Bevacizumab — DRUGBevacizumab will be administered at protocol defined dose.
- FOLFOX — DRUGFOLFOX will be administered at protocol defined dose.
Study Details
The purpose of this study is to evaluate the efficacy and safety of standard-of-care chemotherapy and bevacizumab with or without INCA33890 in the first-line treatment of metastatic microsatellite stable colorectal cancer.
Key Dates
- Start date
- Mar 5, 2026
- Status verified
- May 2026
- Primary completion
- Dec 29, 2028
- Completion
- Sep 28, 2029
Study Design
- Enrollment
- 700 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: INCA33890INCA33890 will be administered in combination with bevacizumab and FOLFOX at the protocol-defined dose.
- Placebo Comparator: PlaceboPlacebo will be administered in combination with bevacizumab and FOLFOX at the protocol-defined dose.
Primary Outcome Measure
Progression-Free Survival (PFS) [ Time Frame: Up to 3 years ]
Central Contacts
- Incyte Corporation Call Center (US)1.855.463.3463
- Incyte Corporation Call Center (ex-US)+800 00027423
Locations (80)
Find similar trials in Chandler, AZ
By research site
Ironwood Cancer & Research Centers· Chandler, AZRoche Tissue Diagnostics, Companion Diagnostics· Tucson, AZThe University of Arizona Cancer Center· Tucson, AZLos Angeles Cancer Network· Anaheim, CAMemorial Care Orange Coast Medical Center· Fountain Valley, CAProvidence Medical Foundation· Fullerton, CA
Related Studies
- A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid MalignanciesPHASE1 · Recruiting · Kumquat Biosciences Inc. · Phoenix, Arizona
- A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS MutationsPHASE1 · Recruiting · Alterome Therapeutics, Inc. · Orlando, Florida
- BBO-11818 in Adult Subjects With KRAS Mutant CancerPHASE1 · Recruiting · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · Los Angeles, California
- An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.PHASE2 · Recruiting · NGM Biopharmaceuticals, Inc · Los Angeles, California